Lipopolysaccharide and lipoteichoic acid influence milk production ability via different early responses in bovine mammary epithelial cells
- 1. Laboratory of Cell and Tissue Biology, Research Faculty of Agriculture, Hokkaido University, North 9, West 9, 060-8589, Sapporo (Japan)
- 2. Laboratory of Animal Genetics and Reproduction, Research Faculty of Agriculture, Hokkaido University, North 9, West 9, 060-8589, Sapporo (Japan)
Description
Highlights: • LPS and LTA affect on the milk production of lactating BMECs in different manners. • LPS/TLR4 and LTA/TLR2 signaling induce different innate immune responses in BMECs. • Inhibition of p38 and NF-κB may help recover decrease in milk production in mastitis. Lipopolysaccharide (LPS) and lipoteichoic acid (LTA) are cell wall components of Escherichia coli and Staphylococcus aureus, which cause clinical and subclinical mastitis, respectively. However, the reason of the difference in symptoms by pathogen type remains unclear. In this study, the influence of LPS and LTA on early response and milk production in lactating bovine mammary epithelial cells (BMECs) was comparatively investigated. The results showed that LPS decreased the secretion of β-casein, lactose, and triglycerides, whereas LTA decreased the secretion of lactose and triglycerides but increased lactoferrin production without any influence on β-casein secretion. In addition, the influence of milk lipid droplet size in BMECs and gene expression related to milk fat synthesis was different between LPS and LTA. LPS increased the gene expression of interleukin (IL)-1β, tumor necrosis factor-α, and IL-8 through the activation of the nuclear factor-κB (NF-κB), p38, and c-Jun N-terminal kinase pathways, whereas LTA increased IL-1β and CC chemokine ligand 5 expression through the activation of the NF-κB pathway. Moreover, these cytokines and chemokines differently affected the milk production ability of BMECs. These results suggested that the pathogen-specific symptoms may be related to the differences in the early response of BMECs to bacterial toxins.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.yexcr.2021.112472Additional details
Identifiers
- DOI
- 10.1016/j.yexcr.2021.112472;
- PII
- S0014482721000033;
Publishing Information
- Journal Title
- Experimental Cell Research
- Journal Volume
- 400
- Journal Issue
- 2
- Journal Page Range
- vp.
- ISSN
- 0014-4827
- CODEN
- ECREAL
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53118958
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- CASEIN; CATTLE; CELL WALL; ESCHERICHIA COLI; LACTATES; LACTOFERRIN; LACTOSE; LIGANDS; LIPOPOLYSACCHARIDES; LYMPHOKINES; MILK; PATHOGENS; PHOSPHOTRANSFERASES; STAPHYLOCOCCUS; SYMPTOMS; TOXINS; TRIGLYCERIDES
- Descriptors DEC
- ANIMALS; ANTIGENS; BACTERIA; BIOLOGICAL MATERIALS; BODY FLUIDS; CARBOHYDRATES; CARBOXYLIC ACID SALTS; CELL CONSTITUENTS; DISACCHARIDES; DOMESTIC ANIMALS; ENZYMES; ESTERS; FOOD; GLOBULINS; GLUCOPROTEINS; GLYCOPROTEINS; GROWTH FACTORS; HAZARDOUS MATERIALS; LIPIDS; MAMMALS; MATERIALS; METALLOPROTEINS; MICROORGANISMS; MITOGENS; OLIGOSACCHARIDES; ORGANIC COMPOUNDS; ORGANIC PHOSPHORUS COMPOUNDS; ORGANOMETALLIC COMPOUNDS; PHOSPHORUS-GROUP TRANSFERASES; POLYSACCHARIDES; PROTEINS; RUMINANTS; SACCHARIDES; TOXIC MATERIALS; TRANSFERASES; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier Inc. All rights reserved.